Evidence map›Paper›PMID 39176477›Full record

ArticleAnnals of surgery2026

Efficacy of Self-Expandable Absorbable Stents During Liver Transplant to Minimize Early Biliary Complications.

Victor Lopez-Lopez, Christoph Kuemmerli, Maria Iniesta-Cortes, Alberto Hiciano-Guillermo, Pedro Cascales-Campos, Alberto Baroja-Mazo, Jose Antonio-Pons, Ignacio Sánchez-Esquer, David Ferreras, Francisco Sánchez-Bueno and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Victor Lopez-LopezDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Christoph KuemmerliDepartment of Surgery, Clarunis-University Center for Gastrointestinal and Liver Diseases Basel, Switzerland.
Maria Iniesta-CortesDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Alberto Hiciano-GuillermoDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Pedro Cascales-CamposDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Alberto Baroja-MazoDigestive and Endocrine Surgery and Transplantation of Abdominal Organs Research Group, Biomedical Research Institute of Murcia (IMIB), Murcia, Spain.
Jose Antonio-PonsDepartment of Hepatology, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Ignacio Sánchez-EsquerDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
David FerrerasDepartment of General and Digestive Surgery, Hospital Universitario de Torrevieja, Alicante, Spain.
Francisco Sánchez-BuenoDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Pablo RamírezDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.
Ricardo Robles-CamposDepartment of General and Digestive Surgery, Virgen de la Arrixaca University Hospital, IMIB-Arrixaca, Murcia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe analyzed the use of a self-expandable absorbable biliary stent (SEABS) to reduce biliary complications in liver transplant (LT).

backgroundComplications related to biliary anastomosis are still a challenge in LT, with a high impact on patient outcomes and hospital costs.

methodsThis nonrandomized prospective study was conducted between July 2019 and September 2023 in adult LT patients with duct-to-duct biliary anastomoses. The primary endpoint was to assess early biliary complications at 90 days in LT patients with intraoperative SEABS versus no SEABS. We also compared overall biliary complications, costs, and SEABS adverse effects related.

resultsA total of 158 patients were included, 78 with SEABS and 80 no-SEABS (22 T-tube and 58 no-stent). There were no adverse effects related to SEABS. Early biliary complications (23.8 vs 2.6%, P <0.001) and hospital stay (19 vs 15 days, P = 0.001) were higher in no-SEABS. No-SEABS group required 63 endoscopic retrograde cholangiopancreatography and 13 surgeries (including 2 LT) versus 35 endoscopic retrograde cholangiopancreatography and 2 surgeries in SEABS group. After PSM between SEABS (n=58) versus no-SEABS (n=58), early biliary complications (22.4% vs 0%, P <0.001) were higher in no-SEABS group. T-tube had more early biliary complications (22.7% vs 5%, P =0.23) compared with SEABS high-risk biliary anastomosis. SEABS excess cost per patient was lower compared with T-Tube and no-stent (6.988€ vs 17.992€ vs 36.364€, P =0.036 and 0.002, respectively).

conclusionsSEABS during biliary anastomosis in LT is feasible with no adverse effects and avoids the T-tube in high-risk biliary anastomoses. Its use has been associated with less early biliary complications, hospital costs, and reoperations or interventional treatments for biliary complications resolution.

Indexed as

Absorbable ImplantsBiliary Tract DiseasesLiver TransplantationPostoperative ComplicationsStentsAdultAgedAnastomosis, SurgicalFemaleHumansMaleMiddle AgedProspective StudiesTreatment Outcomeabsorbable stentbiliary complicationscost analysisliver transplantoutcomes

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.